Clinical Trial

The Medacta Quadra-P Anteverted Study

Name: The Medacta Quadra-P Anteverted Study — clinical trial record (NCT05460715)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting

View on ClinicalTrials.gov →

Summary

This is a Post-Marketing Surveillance of Quadra-P anteverted stem prosthesis.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2022-07-14; most recent amendment 2025-09-23.

Status change: Recruiting → Active, Not Recruiting 2025-09-23

Trial Details

NCT Number	NCT05460715
Lead Sponsor	Medacta International SA
Conditions	Arthrosis, Traumatic Arthritis, Rheumatoid Polyarthritis, Congenital Hip Dysplasia, Avascular Necrosis of the Femoral Head
Enrollment	300 participants
Start Date	2021-07-30
Primary Completion	2032-07 (estimated)
Study Completion	2032-07 (estimated)
Updated on ClinicalTrials.gov	2025-09-29